CAS: 174636-32-9 - (-)-3-Hydroxy-2-phenyl-N-[1(S)-phenylpropyl]quinoline-4-carboxamide
Formula:C25H22N2O2
InChI:InChI=1S/C25H22N2O2/c1-2-20(17-11-5-3-6-12-17)27-25(29)22-19-15-9-10-16-21(19)26-23(24(22)28)18-13-7-4-8-14-18/h3-16,20,28H,2H2,1H3,(H,27,29)/t20-/m0/s1
InChI key:InChIKey=BIAVGWDGIJKWRM-FQEVSTJZSA-N
SMILES:O=C(NC(C=1C=CC=CC1)CC)C2=C(O)C(=NC=3C=CC=CC32)C=4C=CC=CC4
- Synonyms:
- 3-Hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]-4-quinolinecarboxamide
- 3-hydroxy-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide
- 3-hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide
- 4-Quinolinecarboxamide, 3-hydroxy-2-phenyl-N-(1-phenylpropyl)-, (S)-
- 4-Quinolinecarboxamide, 3-hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]-
- Sb-223412
- Talnetant
4-Quinolinecarboxamide, 3-hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]-
CAS:174636-32-9
Formula:
C25H22N2O2
Purity:
95%
Color and Shape:
Solid
Molecular weight:
382.4544
Ref: IN-DA001ZU9
5mg | 155.00 € | ||
10mg | 246.00 € | ||
50mg | 260.00 € | ||
100mg | 576.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Talnetant
CAS:174636-32-9
Talnetant (SB 223412) is a selective NK3 receptor antagonist that can penetrate the brain and …
Formula:
C25H22N2O2
Purity:
≥95%
Color and Shape:
Solid
Molecular weight:
382.45
Ref: TM-T7549
1mg | 42.00 € | ||
2mg | 55.00 € | ||
5mg | 91.00 € | ||
10mg | 127.00 € | ||
25mg | 261.00 € | ||
50mg | 479.00 € | ||
100mg | 728.00 € | ||
1mL*10mM (DMSO) | 142.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Talnetant
Controlled ProductCAS:174636-32-9
Formula:
C25H22N2O2
Color and Shape:
Neat
Molecular weight:
382.45
Ref: TR-T005545
1g | 269.00 € | ||
10g | 1,758.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Talnetant
CAS:174636-32-9
Talnetant is a versatile compound that has various applications in the field of research chemicals. …
Formula:
C25H22N2O2
Purity:
Min. 95%
Molecular weight:
382.45 g/mol
Ref: 3D-ZGA63632
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025